Can-Fite BioPharma (CANF) Return on Equity [ROE] (2013 - 2023)
Can-Fite BioPharma's Return on Equity [ROE] was -178.24% in FY2025, down 43.29 percentage points from -134.94% in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Return on Equity [ROE] (2013 - 2023) Analysis & Trends
From FY2013 onward, Can-Fite BioPharma has reported Return on Equity [ROE] for 11 years.
- Return on Equity [ROE] shows a five-year change of +160.96 percentage points (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Return on Equity [ROE] since FY2020.
- Per Business Quant data, Return on Equity [ROE] in earlier years was -134.94% in FY2024 (+7.55 pp), -142.49% in FY2023 (-61.51 pp), -80.98% in FY2022 (+42.36 pp) and -123.34% in FY2021 (+215.86 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Can-Fite BioPharma | 2.16 Mn | -17.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -137.83% |
| Sep 30, 2023 | -111.29% |
| Jun 30, 2023 | -97.68% |
| Mar 31, 2023 | -122.05% |
| Dec 31, 2022 | -128.30% |
| Sep 30, 2022 | -130.16% |
| Jun 30, 2022 | -110.81% |
| Mar 31, 2022 | -99.76% |
| Dec 31, 2021 | -106.38% |
| Sep 30, 2021 | -182.56% |
| Jun 30, 2021 | -204.93% |
| Mar 31, 2021 | -182.16% |
| Dec 31, 2020 | -151.74% |
| Sep 30, 2020 | -119.40% |
| Jun 30, 2020 | -264.05% |
| Dec 31, 2019 | -201.87% |
| Sep 30, 2019 | -145.45% |
| Dec 31, 2018 | -139.78% |
| Sep 30, 2018 | -221.68% |
| Jun 30, 2018 | -120.62% |
API Access
Can-Fite BioPharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();